The term "AZR1" does not correspond to any established gene symbol, protein designation, or antibody target in current biomedical databases (e.g., UniProt, HUGO Gene Nomenclature Committee). Possible scenarios include:
Typographical Error: The query may refer to ADAR1 (Adenosine Deaminase Acting on RNA 1) or ACVR1 (Activin A Receptor Type 1), both of which are well-characterized targets with commercially available antibodies.
Obsolete Terminology: "AZR1" could represent outdated nomenclature for a receptor or enzyme not widely recognized in contemporary literature.
ADAR1 is an RNA-editing enzyme critical for post-transcriptional modification. Key findings from the search results include:
ADAR1 edits RNA substrates such as BLCAP, GRIA2, and HTR2C, altering protein function .
Plays dual roles in viral infections: proviral (e.g., HIV-1) and antiviral (e.g., HCV) .
ACVR1 is a bone morphogenetic protein (BMP) receptor implicated in heterotopic ossification (HO). Key insights:
Anti-ACVR1 antibodies unexpectedly aggravate HO in fibrodysplasia ossificans progressiva (FOP) models by promoting osteogenic differentiation of fibro-adipogenic progenitors (FAPs) .
Fragment antigen-binding (Fab) regions of these antibodies show therapeutic potential in inhibiting HO .
Verify Target Specificity: Confirm whether "AZR1" corresponds to ADAR1, ACVR1, or another receptor/enzyme.
Explore Orthogonal Databases: Consult resources like the Human Protein Atlas or CiteAb for antibody validation data.
Consider Functional Analogues: If studying RNA editing or HO, prioritize ADAR1 or ACVR1 antibodies with established roles in these pathways.
No peer-reviewed studies or commercial products reference "AZR1 Antibody."
Potential mismatches in nomenclature underscore the need for precise terminology in antibody research.
KEGG: sce:YGR224W
STRING: 4932.YGR224W
AZR1 (Acetic acid and Zinc Resistance 1) is a transmembrane transporter protein identified in yeasts including Saccharomyces cerevisiae (gene YGR224W) and Schizosaccharomyces pombe (gene SPAC1556.03) . The protein plays a critical role in stress response mechanisms, particularly adaptation to short-chain organic acids and zinc stress conditions.
When selecting antibodies against AZR1, researchers should consider:
Species specificity: Ensure the antibody recognizes your specific yeast species (S. cerevisiae or S. pombe)
Application compatibility: Verify validation for your intended application (Western blot, immunofluorescence, etc.)
Epitope location: For membrane proteins like AZR1, antibodies targeting extracellular domains may be preferable for certain applications
Validation method: Look for antibodies validated in knockout systems to confirm specificity
AZR1 antibodies can be employed in multiple experimental contexts:
| Application | Recommended Dilution | Special Considerations |
|---|---|---|
| Western blotting | 1:500-1:1000 | Sample preparation requires membrane protein extraction protocols |
| Immunofluorescence | 1:100-1:500 | Requires specialized yeast cell wall digestion |
| Immunoprecipitation | 2-5 μg/mg protein | Use detergents optimized for membrane proteins |
| Flow cytometry | 1:50-1:200 | Requires effective cell permeabilization |
For membrane proteins like AZR1, standard protocols often require modification. Special attention should be paid to membrane solubilization using appropriate detergents such as digitonin or n-dodecyl-β-D-maltoside (DDM) during sample preparation .
Proper validation is crucial for generating reliable data with AZR1 antibodies:
Genetic validation: The gold standard approach is comparing antibody reactivity between wild-type yeast and AZR1 knockout strains . The absence of signal in knockout strains confirms specificity.
Recombinant expression: Express tagged AZR1 in yeast and confirm co-localization of antibody signal with the tag detection .
Peptide competition: Pre-incubate the antibody with the immunizing peptide before application. Specific signals should be blocked by this treatment .
Cross-reactivity assessment: Test the antibody against related transporter proteins to ensure specificity within the protein family.
Western blot molecular weight confirmation: Verify the detected band matches the predicted molecular weight of AZR1 (~65 kDa) with appropriate controls for glycosylation or other post-translational modifications.
AZR1's role in stress adaptation makes it an excellent model for studying cellular stress responses:
Stress induction time course:
Subcellular fractionation analysis:
Separate membrane fractions from cytosolic components
Quantify changes in AZR1 distribution between fractions during stress response
Correlate with cell survival metrics to establish functional relationships
Signaling pathway interrogation:
Combine AZR1 antibody detection with analysis of known stress response pathways
ASK1 (Apoptosis Signal-regulating Kinase 1) signaling is particularly relevant as it mediates responses to various stressors including oxidative stress
Compare AZR1 expression patterns in wild-type versus ASK1-deficient cells
The MAP kinase pathways, particularly those involving p38 and JNK activation, interface with membrane transporters during stress response. Research has shown that ASK1 regulates p38/JNK signaling during cellular stress, which may interact with AZR1 function .
Immunoprecipitating membrane proteins like AZR1 presents unique challenges requiring specialized protocols:
Optimized co-immunoprecipitation protocol for AZR1:
Cell preparation and lysis:
Grow yeast to mid-log phase (OD600 of 0.6-0.8)
For stress response studies, apply appropriate stressor 30-60 minutes before harvest
Prepare spheroplasts using zymolyase (1 mg/ml, 30 minutes at 30°C)
Lyse cells in buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 1% digitonin or DDM
Include protease and phosphatase inhibitor cocktails
Maintain samples at 4°C throughout processing
Immunoprecipitation:
Pre-clear lysate with Protein A/G beads for 1 hour
Incubate with 2-5 μg AZR1 antibody per mg of protein (overnight, 4°C)
Add fresh Protein A/G beads and incubate for additional 3 hours
Wash 5 times with decreasing detergent concentration (0.5% to 0.1%)
Elution and analysis:
Elute bound proteins with pH gradient or SDS sample buffer (avoid boiling)
Analyze by Western blot or mass spectrometry
This approach has been effectively used for membrane transporters and can be adapted for AZR1 to identify novel interaction partners involved in stress response pathways .
Visualizing membrane proteins in yeast requires specialized immunofluorescence approaches:
Cell wall removal and fixation:
Membrane permeabilization optimization:
Test a gradient of detergent concentrations (0.05%-0.5% Triton X-100)
For membrane proteins, saponin (0.1%) often provides better epitope preservation
Optimize time and temperature for permeabilization
Blocking and antibody incubation:
Block with 3-5% BSA in PBS with 0.1% detergent (1 hour)
Incubate with primary AZR1 antibody (typically 1:100-1:500) overnight at 4°C
Use fluorescently-labeled secondary antibodies at manufacturer's recommended dilution
Controls and co-localization:
Include membrane markers for co-localization studies
Use AZR1 knockout strains as negative controls
Consider AZR1-tagged constructs as positive controls
The challenges in immunofluorescence detection of AZR1 are similar to those faced when studying other yeast membrane proteins, requiring careful optimization of each step .
Post-translational modifications (PTMs) often regulate transporter function and can be studied using antibody-based approaches:
Phosphorylation analysis:
Immunoprecipitate AZR1 using validated antibodies
Analyze by Western blot with phospho-specific antibodies
Alternatively, use phospho-protein enrichment followed by AZR1 detection
Include λ-phosphatase treatment as a control
Ubiquitination detection:
Perform denaturing immunoprecipitation to disrupt protein interactions
Probe with anti-ubiquitin antibodies
Consider proteasome inhibitor treatment to enhance detection
Sample preparation considerations:
Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride)
Add deubiquitinase inhibitors (N-ethylmaleimide)
Maintain low temperature throughout processing
PTM site identification:
After immunoprecipitation with AZR1 antibodies, perform mass spectrometry
Compare PTM patterns under different stress conditions
Correlate with functional changes in AZR1 activity
Understanding AZR1 post-translational modifications can provide critical insights into how this transporter is regulated during stress responses .
Working with AZR1 antibodies across S. cerevisiae and S. pombe presents several challenges:
| Challenge | Solution | Technical Details |
|---|---|---|
| Sequence variations between species | Use antibodies targeting conserved epitopes | Sequence alignment shows 62% similarity in the conserved domains |
| Different extraction efficiencies | Optimize lysis protocols for each species | S. pombe typically requires stronger mechanical disruption |
| Variable expression levels | Adjust antibody dilutions by species | Expression may be 2-3× higher in S. cerevisiae under standard conditions |
| Cross-reactivity concerns | Validate specificity in each species | Use respective knockout strains as controls |
A comprehensive validation approach in both species includes:
Testing antibody performance in wild-type and knockout strains of each species
Comparing recognition of recombinant proteins from both yeasts
Optimizing fixation and extraction conditions separately for each species
Yeast display technology offers powerful approaches for antibody development against challenging targets like AZR1:
Library construction and screening strategy:
Technical optimization for membrane protein targets:
Express properly folded AZR1 domains by incorporating membrane mimetics
Use detergent-solubilized or nanodiscs-incorporated AZR1 as target
Include biotinylated target protein for detection with fluorescent streptavidin
Selection process:
Perform multiple rounds of magnetic and flow cytometric sorting
Gradually increase selection stringency
Counter-select against related transporters to ensure specificity
Validation of selected antibodies:
Express and purify selected antibody candidates
Test binding to native AZR1 in yeast cells
Verify specificity using knockout controls
Recent advancements in yeast display technology have enabled the development of antibodies against challenging membrane protein targets, making this approach feasible for AZR1 .
AZR1 expression varies significantly under different conditions, affecting antibody detection:
| Growth Condition | Expected AZR1 Expression | Antibody Dilution Adjustment | Rationale |
|---|---|---|---|
| Standard media (YPD/YES) | Low/Basal | 1:500 | Constitutive expression level |
| Acetic acid stress (0.1-0.5%) | High (3-5× increase) | 1:1000-1:2000 | Transporter upregulation for adaptation |
| Zinc stress conditions | Moderate-High | 1:1000 | Secondary function in zinc transport |
| Stationary phase | Moderate | 1:750 | Stress response activation |
For accurate experimental planning:
Include appropriate positive controls from cells under stress conditions
Design time-course experiments to capture transient expression changes
Consider adjusting antibody concentrations based on expected expression levels
Use loading controls appropriate for membrane proteins
This response pattern aligns with AZR1's role in adapting to environmental stresses through modified membrane transport activity .
Ensuring specificity when detecting AZR1 versus related transporters requires careful experimental design:
Cross-reactivity assessment:
Test antibody against lysates from cells expressing related transporters
Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins
Compare binding patterns between wild-type and AZR1 knockout strains
Epitope mapping and selection:
Choose antibodies targeting unique regions of AZR1 not conserved in related transporters
Consider generating custom antibodies against specific AZR1 domains
Use peptide competition assays with AZR1-specific peptides
Validation strategy:
Express epitope-tagged AZR1 in yeast
Compare antibody detection with tag-specific antibody detection
Verify signals disappear in knockout strains
Controls for experiments:
Include samples from cells overexpressing related transporters
Use gradient SDS-PAGE to resolve proteins of similar molecular weights
Consider 2D gel electrophoresis for complex samples
This approach is particularly important given that yeast genomes encode multiple transporters with similar structures and functions .
The potential relationship between AZR1 (a membrane transporter) and ASK1 (a key stress response kinase) represents an interesting area for investigation:
Signaling pathway integration:
Experimental approach to investigate interactions:
Compare AZR1 expression and localization in wild-type versus ASK1-deficient cells
Analyze phosphorylation status of AZR1 after stress induction
Test if ASK1 inhibitors affect AZR1 transport activity
Potential mechanism of interaction:
ASK1 signaling may phosphorylate AZR1 directly or via downstream kinases
Altered AZR1 activity could affect intracellular pH or ion concentrations, feeding back to ASK1 pathways
Both proteins contribute to stress adaptation through potentially complementary mechanisms
Research has shown that ASK1 plays critical roles in responses to various cellular stresses, including those that would activate membrane transporters like AZR1 .
Antibody-based approaches can dissect AZR1's specific contributions to stress adaptation:
Expression pattern analysis:
Use AZR1 antibodies to quantify protein levels under different stress conditions
Compare expression kinetics across multiple stressors (acetic acid, zinc, oxidative stress)
Correlate with cell survival metrics to establish functional relationships
Localization studies:
Track AZR1 subcellular distribution during stress response
Identify potential re-localization events that correlate with adaptation
Co-localize with other stress response proteins to identify functional complexes
Protein interaction networks:
Immunoprecipitate AZR1 at different time points during stress response
Identify dynamic interaction partners using mass spectrometry
Map AZR1-centered protein networks that mediate adaptation
Functional inhibition studies:
Test whether function-blocking AZR1 antibodies affect stress survival
Compare with genetic knockout effects to distinguish direct versus compensatory effects
These approaches can reveal how AZR1 integrates into broader cellular stress response mechanisms, particularly related to membrane transport regulation .
Recent advances in antibody engineering offer new possibilities for studying AZR1 function:
Chemically expanded antibody libraries:
Recent research has developed billion-member antibody libraries with non-canonical amino acids
These modified antibodies can incorporate reactive groups capable of:
Photo-crosslinking to capture transient interactions
Click chemistry for targeted labeling
Proximity-induced reactions for activity studies
Functional applications for AZR1 research:
Developing antibodies that can irreversibly bind active conformations of AZR1
Creating antibodies that can report on AZR1 transport activity
Designing antibodies that modulate transporter function
Technical considerations:
Screening can be performed using yeast display systems
Flow cytometry enables high-throughput selection of antibodies with desired properties
Biochemical validation requires careful characterization of binding and functional effects
This approach could yield research tools that go beyond simple detection, providing reagents that report on or manipulate AZR1 functional states .
Developing phospho-specific antibodies for AZR1 requires specialized approaches:
Phosphorylation site identification:
Perform phosphoproteomic analysis of AZR1 under various conditions
Prioritize sites showing dynamic regulation during stress response
Consider evolutionary conservation of phosphorylation sites
Custom antibody development strategy:
Design phosphopeptides containing the phosphorylation site of interest
Synthesize both phosphorylated and non-phosphorylated peptides
Immunize with phosphopeptide conjugated to carrier protein
Deplete non-phospho-specific antibodies by absorption with non-phosphorylated peptide
Validation requirements:
Test antibody against wild-type and phospho-site mutant AZR1 (S/T→A or Y→F)
Verify phosphatase treatment eliminates signal
Confirm specificity using peptide competition
Applications:
Monitor AZR1 phosphorylation status during stress adaptation
Identify conditions that trigger specific phosphorylation events
Correlate phosphorylation with changes in transporter activity
Phospho-specific antibodies would provide valuable tools for understanding how post-translational modifications regulate AZR1 function during stress responses .